# Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

> **NCT00982280** · PHASE3 · TERMINATED · sponsor: **Grünenthal GmbH** · enrollment: 82 (actual)

## Conditions studied

- Chronic Pain
- Osteoarthritis

## Interventions

- **DRUG:** Tapentadol PR

## Key facts

- **NCT ID:** NCT00982280
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2010-05
- **Final completion:** 2010-08
- **Target enrollment:** 82 (ACTUAL)
- **Why stopped:** Slow Recruitment and supply of Investigational Medicinal Product Issues
- **Last updated:** 2019-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982280, "Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00982280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*